Creso Pharma Limited has completed all required importing and exporting procedures and successfully delivered the second shipment of cannaQIX® products to the subsidiary of Lupin International, Pharma Dynamics South Africa. As a company that prides itself on bringing the best of cannabis to better the lives of people and animals, management would be extremely encouraged with this repeat business, a true endorsement of product quality and operational performance. One of Creso’s key goals is to bring pharmaceutical expertise and methodological rigor to the cannabis world as it strives for the highest quality in its products. The group’s ability to succeed in this quest is paying dividends as it emerges as an important player in the development of cannabis and hemp-derived therapeutic, nutraceutical, and lifestyle products with a wide patient and consumer reach for human and animal health.
Sean Hocking, Cannabis Law Report, 01/12/2021 19:58:00